Inventaire - your friends and communities are your best library

Leukotriene-receptor antagonists

Published in: The Lancet

Date of publication: January 1, 1999

Language: English

Bibliographic databases:

Cites articles 32

Date

Title

Authors

December 1, 1980

Leukotrienes are potent constrictors of human bronchi
December 1, 1990

Reduced Allergen-Induced Nasal Congestion and Leukotriene Synthesis with an Orally Active 5-Lipoxygenase Inhibitor
March 1, 1991

Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects
October 1, 1991

The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma
May 1, 1991

The role of leukotrienes in allergic rhinitis: a review
June 1, 1993

Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion
September 1, 1994

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group
April 1994

Effect of oral prednisone on airway inflammatory mediators in atopic asthma
June 1, 1995

The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis
February 1, 1996

Airway and systemic effects of inhaled corticosteroids in asthma: dose response relationship
March 1, 1996

Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females
February 1, 1997

Pharmacology of leukotriene receptor antagonists. More than inhibitors of bronchoconstriction
February 1, 1997

Leukotrienes in the pathogenesis of asthma
December 1, 1997

Pharmacokinetics and bioavailability of montelukast sodium (MK-0476) in healthy young and elderly volunteers
June 1, 1997

Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics
July 1, 1997

Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group
February 1, 1997

Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial
November 1, 1997

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group
May 1, 1997

Dexamethasone increases expression of 5-lipoxygenase and its activating protein in human monocytes and THP-1 cells,Dexamethasone Increases Expression of 5‐Lipoxygenase and its Activating Protein in Human Monocytes and THP‐1 Cells
March 1, 1997

Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription
January 1, 1998

Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma
August 1, 1998

Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects
May 1, 1998

Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge
October 1, 1998

Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma
June 1, 1998

Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group
July 1, 1998

A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group
April 1, 1998

Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group
June 1, 1998

Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group
February 15, 1998

Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma

, , , ,
July 1, 1998

Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction,Montelukast, a Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced Bronchoconstriction
September 1, 1998

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma
February 1, 1998

Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast,Pulmonary Infiltrates, Eosinophilia, and Cardiomyopathy Following Corticosteroid Withdrawal in Patients With Asthma Receiving Zafirlukast

Article -

Welcome to inventaire

The library of your friends and communities

Learn more